The Use of Pharmacological Retromer Chaperones in Alzheimer’s Disease and Other Endosomal-Related Disorders

Neurotherapeutics - United States
doi 10.1007/s13311-014-0321-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Retromer in Alzheimer Disease, Parkinson Disease and Other Neurological Disorders

Nature Reviews Neuroscience
Neuroscience
2015English

Copper Status in Alzheimer’s Disease and Other Neurodegenerative Disorders 2013

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2013English

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Neurology and Therapy
Neurology
2019English

Endosomal Sorting: Architecture of the Retromer Coat

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2018English

ICT for Assessment and Rehabilitation in Alzheimer’s Disease and Related Disorders

Frontiers Research Topics
2016English

Recruitment, Retention and Other Methodological Issues Related to Clinical Trials for Alzheimer’s Disease

Journal of Nutrition, Health and Aging
MedicineNutritionGerontologyGeriatricsDietetics
2012English

The Functional Roles of Retromer in Parkinson's Disease

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2017English

Detection of Serum IgG4 Levels in Patients With IgG4-Related Disease and Other Disorders

PLoS ONE
Multidisciplinary
2015English

436 the Role of the Endosomal Trafficking Complex, the Retromer, in Regulating Desmoglein-1 Localization

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy